These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23591192)

  • 1. A prospective study of plasma inflammatory markers and risk of colorectal cancer in men.
    Song M; Wu K; Ogino S; Fuchs CS; Giovannucci EL; Chan AT
    Br J Cancer; 2013 May; 108(9):1891-8. PubMed ID: 23591192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs.
    Chan AT; Ogino S; Giovannucci EL; Fuchs CS
    Gastroenterology; 2011 Mar; 140(3):799-808, quiz e11. PubMed ID: 21115010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
    Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
    BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma inflammatory biomarkers and modifiable lifestyle factors associated with colorectal cancer risk.
    Kim J; Lee J; Oh JH; Chang HJ; Sohn DK; Shin A; Kim J
    Clin Nutr; 2020 Sep; 39(9):2778-2785. PubMed ID: 31883943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women.
    Song M; Mehta RS; Wu K; Fuchs CS; Ogino S; Giovannucci EL; Chan AT
    Cancer Prev Res (Phila); 2016 Jan; 9(1):27-34. PubMed ID: 26511487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between post-treatment circulating biomarkers of inflammation and survival among stage II-III colorectal cancer patients.
    Hua X; Kratz M; Malen RC; Dai JY; Lindström S; Zheng Y; Newcomb PA
    Br J Cancer; 2021 Sep; 125(6):806-815. PubMed ID: 34230610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Markers of CRP, IL6, TNFα, and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies.
    Zeng F; Wei H; Yeoh E; Zhang Z; Ren ZF; Colditz GA; Tworoger SS; Su X
    Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1231-9. PubMed ID: 27277846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory biomarkers, aspirin, and risk of colorectal cancer: Findings from the physicians' health study.
    Kim C; Zhang X; Chan AT; Sesso HD; Rifai N; Stampfer MJ; Ma J
    Cancer Epidemiol; 2016 Oct; 44():65-70. PubMed ID: 27504605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic signatures of inflammation and metabolic dysregulation in relation to colorectal cancer risk.
    Bever AM; Hang D; Lee DH; Tabung FK; Ugai T; Ogino S; Meyerhardt JA; Chan AT; Eliassen AH; Liang L; Stampfer MJ; Song M
    J Natl Cancer Inst; 2024 Jul; 116(7):1126-1136. PubMed ID: 38430005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers.
    Seddon JM; George S; Rosner B; Rifai N
    Arch Ophthalmol; 2005 Jun; 123(6):774-82. PubMed ID: 15955978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker patterns of inflammatory and metabolic pathways are associated with risk of colorectal cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Aleksandrova K; Jenab M; Bueno-de-Mesquita HB; Fedirko V; Kaaks R; Lukanova A; van Duijnhoven FJ; Jansen E; Rinaldi S; Romieu I; Ferrari P; Murphy N; Gunter MJ; Riboli E; Westhpal S; Overvad K; Tjønneland A; Halkjær J; Boutron-Ruault MC; Dossus L; Racine A; Trichopoulou A; Bamia C; Orfanos P; Agnoli C; Palli D; Panico S; Tumino R; Vineis P; Peeters PH; Duell EJ; Molina-Montes E; Quirós JR; Dorronsoro M; Chirlaque MD; Barricarte A; Ljuslinder I; Palmqvist R; Travis RC; Khaw KT; Wareham N; Pischon T; Boeing H
    Eur J Epidemiol; 2014 Apr; 29(4):261-75. PubMed ID: 24791703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein, interleukin-6, soluble tumor necrosis factor α receptor 2 and incident clinical depression.
    Chocano-Bedoya PO; Mirzaei F; O'Reilly EJ; Lucas M; Okereke OI; Hu FB; Rimm EB; Ascherio A
    J Affect Disord; 2014 Jul; 163():25-32. PubMed ID: 24836084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality.
    Mehta RS; Chong DQ; Song M; Meyerhardt JA; Ng K; Nishihara R; Qian Z; Morikawa T; Wu K; Giovannucci EL; Fuchs CS; Ogino S; Chan AT
    Gastroenterology; 2015 Sep; 149(3):614-22. PubMed ID: 26026393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Markers of systemic inflammation and colorectal adenoma risk: Meta-analysis of observational studies.
    Godos J; Biondi A; Galvano F; Basile F; Sciacca S; Giovannucci EL; Grosso G
    World J Gastroenterol; 2017 Mar; 23(10):1909-1919. PubMed ID: 28348498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study of macrophage inhibitory cytokine-1 (MIC-1/GDF15) and risk of colorectal cancer.
    Mehta RS; Song M; Bezawada N; Wu K; Garcia-Albeniz X; Morikawa T; Fuchs CS; Ogino S; Giovannucci EL; Chan AT
    J Natl Cancer Inst; 2014 Apr; 106(4):dju016. PubMed ID: 24565956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study.
    Prizment AE; Anderson KE; Visvanathan K; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):297-307. PubMed ID: 21217085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis.
    Zhou B; Shu B; Yang J; Liu J; Xi T; Xing Y
    Cancer Causes Control; 2014 Oct; 25(10):1397-405. PubMed ID: 25053407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.
    Shiels MS; Katki HA; Hildesheim A; Pfeiffer RM; Engels EA; Williams M; Kemp TJ; Caporaso NE; Pinto LA; Chaturvedi AK
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26220734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study.
    Izano M; Wei EK; Tai C; Swede H; Gregorich S; Harris TB; Klepin H; Satterfield S; Murphy R; Newman AB; Rubin SM; Braithwaite D;
    Int J Cancer; 2016 Mar; 138(5):1118-28. PubMed ID: 26413860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating inflammatory markers and colorectal cancer risk: A prospective case-cohort study in Japan.
    Song M; Sasazuki S; Camargo MC; Shimazu T; Charvat H; Yamaji T; Sawada N; Kemp TJ; Pfeiffer RM; Hildesheim A; Pinto LA; Rabkin CS; Tsugane S
    Int J Cancer; 2018 Dec; 143(11):2767-2776. PubMed ID: 30132835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.